Código 293410 (Harmonized System 2012 by 6 digits)
2023: US$79.9M, Total Trade Exchange
2023: US$45.4M, International Sales
2023: US$34.4M, International Purchases
In 2023, the trade exchange (includes international purchases and sales) of Heterocyclic Compounds Containing in the Structure Cycle Thiazole, Incl. Hydrogenated Unfused was US$79.9M.
In 2023, the states with the most international sales in Heterocyclic Compounds Containing in the Structure Cycle Thiazole, Incl. Hydrogenated Unfused were Estado de México (US$26.6k).
The states with the most international purchases in 2023 were Ciudad de México (US$13.4M), Nuevo León (US$12.4M), Jalisco (US$1.47M), Morelos (US$807k), and Estado de México (US$770k).
In 2023, the main commercial destinations of Heterocyclic Compounds Containing in the Structure Cycle Thiazole, Incl. Hydrogenated Unfused were Colombia (US$20k), United States (US$5.11k), Chile (US$1.02k), Peru (US$510), and Brazil (US$2).
The main commercial origins of Heterocyclic Compounds Containing in the Structure Cycle Thiazole, Incl. Hydrogenated Unfused in 2023 were Switzerland (US$12.1M), India (US$6.98M), Spain (US$4.85M), China (US$3.12M), and Netherlands (US$844k).
In the global context, the main exporting countries of Heterocyclic Compounds Containing in the Structure Cycle Thiazole, Incl. Hydrogenated Unfused in 2022 were Switzerland (US$1.59B), Ireland (US$902M), and China (US$623M). In the same year, the main importing countries of Heterocyclic Compounds Containing in the Structure Cycle Thiazole, Incl. Hydrogenated Unfused were United States (US$1.34B), Canada (US$1.22B), and Brazil (US$385M).
US$79.9M, Total Trade Exchange (2023)
In 2023, the total trade exchange of Heterocyclic Compounds Containing in the Structure Cycle Thiazole, Incl. Hydrogenated Unfused in Mexico (including international purchases and sales) was US$79.9M.
The visualizations show the net balance of Heterocyclic Compounds Containing in the Structure Cycle Thiazole, Incl. Hydrogenated Unfused at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
Estado de México: US$26.6k, State with the Most International Sales (2023)
Colombia: US$20k, Main commercial destination (2023)
In 2023, the states with the highest international sales in Heterocyclic Compounds Containing in the Structure Cycle Thiazole, Incl. Hydrogenated Unfused were Estado de México (US$26.6k).
In 2023, the countries with the most international purchases from Mexico were Colombia (US$20k), United States (US$5.11k), Chile (US$1.02k), Peru (US$510), and Brazil (US$2).
Ciudad de México: US$13.4M, State with the Most International Purchases (2023)
Switzerland: US$12.1M, Main Commercial Origin (2023)
In 2023, the states with the highest international in Heterocyclic Compounds Containing in the Structure Cycle Thiazole, Incl. Hydrogenated Unfused were Ciudad de México (US$13.4M), Nuevo León (US$12.4M), Jalisco (US$1.47M), Morelos (US$807k), and Estado de México (US$770k).
The countries with the most international sales to Mexico in 2023 were Switzerland (US$12.1M), India (US$6.98M), Spain (US$4.85M), China (US$3.12M), and Netherlands (US$844k).
The RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Heterocyclic Compounds Containing in the Structure Cycle Thiazole, Incl. Hydrogenated Unfused and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Heterocyclic Compounds Containing in the Structure Cycle Thiazole, Incl. Hydrogenated Unfused. On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
The visualizations show the global market for Heterocyclic Compounds Containing in the Structure Cycle Thiazole, Incl. Hydrogenated Unfused. In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Heterocyclic Compounds Containing in the Structure Cycle Thiazole, Incl. Hydrogenated Unfused were Switzerland (US$1.59B), Ireland (US$902M), and China (US$623M). In the same year, the main importing countries for Heterocyclic Compounds Containing in the Structure Cycle Thiazole, Incl. Hydrogenated Unfused were United States (US$1.34B), Canada (US$1.22B), and Brazil (US$385M).